,i  #aafth ,,congress  #ast ,session    
,h4 ,r4 #ccgi  ,,in ,,the ,,house ,,of  
,,representatives  ,june #bj1 #bjai,ms4 
,schakowsky 7for herself1 ,mr4          
,westerman1 ,ms4 ,de,lauro1 ,ms4 ,craig1
 ,mr4 ,doggett1 ,mr4 ,krishnamoorthi1   
,mr4 ,khanna1 ,mr4 ,cicilline1 ,mr4     
,pocan1 ,mr4 ,rush1 ,mr4 ,levin of      
,michigan1 ,mr4 ,morelle1 ,ms4 ,jayapal1
 ,ms4 ,tlaib1 ,ms4 ,kaptur1 ,mr4 ,welch1
 and ,mr4 ,garca of ,illinois7          
introduced the following bill2 which was
 referred to the ,committee on ,energy  
and ,commerce  ,a ,,bill  ,to amend the 
,public ,health ,service ,act to shorten
 the exclusivity period for brand name  
biological products from #ab to #e      
years4  #a4 ,short title ,this ,act may 
be cited as the ,price ,relief1         
,innovation1 and ,competition for       
,essential ,drugs ,act or the ,,priced  
,act4  #b4 ,exclusivity period for brand
 name biological products  7a7 ,in      
general ,section #cea7k77#g77;,a7 of the
 ,public ,health ,service ,act 7#db     

,u4,s4,c4 #bfb7k77#g77;,a77 is amended  
by striking #ab years and inserting #e  
years4  7b7 ,conforming changes         
,paragraphs 7#b77;,a7 and 7#c77;,a7 of  
section #cea7m7 of the ,public ,health  
,service ,act 7#db ,u4,s4,c4 #bfb7m77 is
 amended by striking #ab years each     
place it appears and inserting #e years4
  7c7 ,applicability ,this ,act and the 
amendments made by this ,act apply only 
with respect to a biological product for
 which the reference product 7as such   
term is used in section #cea of the     
,public ,health ,service ,act 7#db      
,u4,s4,c4 #bfb77 is licensed under      
subsection 7a7 of such section on or    
after the date of enactment of this     
,act4